Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

Joshua Melson, MD, MPH

Joshua Melson, MD, MPH
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Gastroenterology
  • Internal Medicine
Board Certification:
  • Gastroenterology
  • Internal Medicine
Faculty Rank: Assistant Professor
Medical or Graduate Education: Indiana University School of Medicine
Residency: Rush University Medical Center - Internal Medicine
Fellowship: Rush University Medical Center - Gastroenterology
Clinical Expertise:
  • Barrett's esophagus
  • Cancer prevention and screening
  • Carcinoid tumor
  • Colonoscopy
  • Colorectal cancer
  • Enteroscopy
  • Enteroscopy, single balloon
  • Esophagogastroduodenoscopy (EGD)
  • Familial adenomatous polyposis (FAP)
  • Gastrointestinal cancers
Research Interests:
  • Barrett's esophagus
  • Hereditary colon cancer
  • Colon cancer screening
Languages Spoken:
  • English
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Advanced Adenoma Detection Rate Is Independent of Nonadvanced Adenoma Detection Rate.
    Greenspan M, Rajan KB, Baig A, Beck T, Mobarhan S, Melson J.
    Am J Gastroenterol. 2013
    2013 May 28. doi: 10.1038/ajg.2013.149. [Epub ahead of print]
  2. Endoscopic mis-sizing of polyps changes colorectal cancer surveillance recommendations.
    Eichenseer PJ, Dhanekula R, Jakate S, Mobarhan S, Melson JE.
    Dis Colon Rectum. 2013
    2013 Mar
    56(3):315-21. doi: 10.1097/DCR.0b013e31826dd138.
  3. PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer.
    Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, Barrett TA, Bentrem DJ, Beckhove P, Khazaie K.
    Clin Cancer Res. 2013
    2013 Apr 12. [Epub ahead of print]
  4. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Cassinotti E, Melson J, Liggett T, Melnikov A, Yi Q, Replogle C, Mobarhan S, Boni L, Segato S, Levenson V.
    Int J Cancer. 2012
    2012 Sep 1
    131(5):1153-7. doi: 10.1002/ijc.26484. Epub 2011 Nov 19.
  5. Histopathology predictors of medically refractory ulcerative colitis.
    Melson JE, Giusto D, Kwasny M, Eichenseer P, Jakate S, Keshavarzian A.
    Dis Colon Rectum. 2010
    2010 Sep
    53(9):1280-6. doi: 10.1007/DCR.0b013e3181e751df.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612